Mounjaro

Mounjaro, containing tirzepatide, is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) medication used to treat type 2 diabetes and aid in weight loss. It's newsworthy due to the increasing popularity of GLP-1 RA drugs like Ozempic and Wegovy for weight management, coupled with emerging concerns about their potential side effects and accessibility. Recent studies and expert opinions highlight both the potential benefits of GLP-1 RAs in addressing obesity and addiction, and the risks associated with their use, including potential vision problems. The development of oral GLP-1 RA alternatives, like orforglipron, is also significant, potentially offering a more accessible and convenient option than injections. Concerns about counterfeit medications and unregulated sales are also rising, emphasizing the need for stricter oversight as these drugs gain wider use.